TRIB2 and acute lymphoblastic leukemia: Mice transplanted with ICN1-transduced Trib2−/− donor cells succumbed to T-ALL disease with a shorter latency (median survival of 43.5 days), whereas mice transplanted with ICN1-transduced WT donor cells had a median survival of 63.5 days.